Skip to content
Menu

Ginkgo Bioworks Holdings, Inc. DNA

Full chart Compare
Set alert

Price alert · DNA

All alert types
7.43 USD -0.77 (-9.39%)

As ofNov 20, 2026, 2:33 PM EST

7.41 Day range 7.76
5.37 52-week range 18.22
YTD
-10.59%
1 year
-4.99%

Revenue & Expenses

Revenue Profit Costs
Other Income$1.68MIncome Tax Benefit$837.00KGross Profit$138.63MNet Loss$312.76MCost of Revenue$31.52MExpenses$453.91MSelling, General & Admin$183.29MResearch & Development$243.77MOther Operating Expenses$26.85MRevenue$170.16M

Latest period ending Dec 31, 2025 · select a line to chart its full history

DNA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
170.16M227.04M251.46M477.71M313.84M
123.18M182.50M197.45M273.49M184.15M
-315.28M-559.76M-864.41M-2.21B-1.83B
-312.76M-547.03M-892.87M-2.10B-1.83B
-5.64-10.54-18.37-50.20-56.00
DNA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
167.20M561.57M944.07M1.32B1.55B
1.12B1.38B1.67B2.54B2.07B
611.11M661.39M568.19M803.04M503.61M
417.08M438.77M221.84M413.26M22.28M
508.59M716.06M1.10B1.74B1.51B
DNA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-171.06M-319.58M-295.50M-252.20M-253.82M
-240.29M-62.24M-80.69M-67.39M-73.26M
17.77M-1.74M-3.22M95.34M1.53B
-7.09M-61.89M-36.37M-52.27M-56.52M
-393.37M-383.84M-380.00M-223.35M1.21B